Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacokinetic Properties of Orally Administered 4′-Cyano-2′-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats

Biological and Pharmaceutical Bulletin(2020)10.1248/bpb.b20-00372Source: DataRank Database

Pharmacokinetic Properties of Orally Administered 4′-Cyano-2′-deoxyguanosine, a Novel Nucleoside Analog Inhibitor of the Hepatitis B Virus, in Viral Liver Injury Model Rats is a research paper published in Biological and Pharmaceutical Bulletin (2020). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.27)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Kazuaki Taguchi ORCID,Shuhei Imoto,Keishi Yamasaki ORCID,Hiroaki Mitsuya ORCID,Masaki Otagiri ORCID

Live enrichment

PubMed:32879218 PMC:PMC8916165 OpenAlex:https://openalex.org/W3081977204

Intramural NIH HHS

Grant: ZIA BC011486

FWCI

0.27

Citation Percentile

0.6%

Citation Trend

2020

2023

gold

journalhttps://www.jstage.jst.go.jp/article/bpb/43/9/43_b20-00372/_pdf

publisherhttps://www.jstage.jst.go.jp/article/bpb/43/9/43_b20-00372/_pdf

journalhttp://doi.org/10.1248/bpb.b20-00372

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32879218

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8916165

Fields of Study

Hepatitis B Virus StudiesHepatitis C virus researchHIV/AIDS drug development and treatmentAdministration, IntravenousAnimalsAntiviral AgentsChemical and Drug Induced Liver InjuryConcanavalin ADeoxyguanosineDisease Models, AnimalDrug Evaluation, PreclinicalFood-Drug InteractionsGastrointestinal AbsorptionHepatitis B, ChronicHumansLiverMaleRats

MeSH Terms

AnimalsAntiviral AgentsConcanavalin ADeoxyguanosineDisease Models, AnimalDrug Evaluation, PreclinicalHumansLiverMaleFood-Drug InteractionsHepatitis B, ChronicRatsChemical and Drug Induced Liver InjuryAdministration, IntravenousGastrointestinal Absorption

Keywords

PharmacokineticsNucleosidePharmacologyDeoxyguanosineLiver injuryNucleoside analogueOral administrationGastrointestinal tractIn vivoInosineMedicineChemistryInternal medicineBiologyBiochemistryAdenosineOxidative stressHepatitis BAcute liver injuryDispositionNucleoside AnalogFood–drug Interaction

Sustainable Development Goals

SDG 0: Good health and well-being